James R. Kasinger insider trades: CRISPR Therapeutics (CRSP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | CRSP | ↓ Sell | 1,040 | $49.26 | $51K | Direct | Oct 15, 2026 (1d) |
| Oct 6, 2026 | CRSP | ↓ Sell | 1,990 | $60.04 | $119K | Direct | Oct 8, 2026 (2d) |
| Sep 22, 2026 | CRSP | ↓ Sell | 10,400 | $60.24 | $626K | Direct | Sep 24, 2026 (2d) |
| Mar 23, 2026 | CRSP | ↓ Sell | 3,182 | $46.78 | $149K | Direct | Mar 24, 2026 (1d) |
| Mar 16, 2026 | CRSP | ↓ Sell | 3,450 | $48.26 | $166K | Direct | Mar 17, 2026 (1d) |
| Mar 11, 2026 | CRSP | ↓ Sell | 2,800 | $52.80 | $148K | Direct | Mar 12, 2026 (1d) |
| Feb 19, 2026 | CRSP | ↓ Sell | 2,112 | $52.58 | $111K | Direct | Feb 20, 2026 (1d) |
| Oct 14, 2025 | CRSP | ↓ Sell | 1,076 | $66.60 | $72K | Direct | Oct 15, 2025 (1d) |
| Mar 21, 2025 | CRSP | ↓ Sell | 3,185 | $41.23 | $131K | Direct | Mar 24, 2025 (3d) |
| Mar 12, 2025 | CRSP | ↓ Sell | 3,966 | $42.67 | $169K | Direct | Mar 12, 2025 (0d) |
| Feb 19, 2025 | CRSP | ↓ Sell | 11,542 | $53.67 | $619K | Direct | Feb 19, 2025 (0d) |
| Oct 14, 2024 | CRSP | ↓ Sell | 1,089 | $46.28 | $50K | Direct | Oct 15, 2024 (1d) |
| Mar 12, 2024 | CRSP | ↓ Sell | 3,947 | $77.15 | $305K | Direct | Mar 12, 2024 (0d) |
| Feb 20, 2024 | CRSP | ↓ Sell | 1,913 | $79.67 | $152K | Direct | Feb 21, 2024 (1d) |
| Jan 19, 2021 | CRSP | ↓ Sell | 27,500 | $204.94 | $5.6M | Direct | Jan 20, 2021 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRSP insiders
Open-market trades in the last 12 months
About James R. Kasinger's insider trades
James R. Kasinger is General Counsel and Secretary at CRISPR Therapeutics (CRSP). Since Jan 19, 2021, James has reported no open-market purchases and 15 sales worth $8.5M on SEC Form 4. In the last 12 months: 7 sales ($1.4M).
Their filings also include option exercises (24 filings), grants and awards (22 filings), shares withheld for taxes (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRSP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.